神经外科30天再入院率:一项有用的质量评估指标?
该研究回顾性分析德国一家神经外科6年内8878例住院患者,评估30天再入院率、再入院原因及作为质量指标的价值。结果显示再入院率为2.9%,最常见原因为手术部位感染,不同疾病再入院原因差异显著(p < 0.001)。多因素回归提示脑积水和较短住院时间与再入院风险相关。作者认为再入院率虽易追踪,但缺乏统一定义且依赖医疗系统,不能单独作为充分的神经外科质量指标。
要点
- 神经外科30天再入院率为2.9%,手术部位感染最常见。
- 不同神经外科疾病再入院原因分布差异显著(p < 0.001)。
- 再入院率作为质量指标需统一定义和风险调整。
核心结论
- 再入院率虽易于追踪且对质量评估有吸引力,但仅凭该率不能充分衡量神经外科质量,因其缺乏统一定义且依赖基础医疗系统,并需要风险调整策略。
研究设计与样本
- 回顾性分析德国一家神经外科6年内8878例住院患者,识别再入院原因并分析基线特征以寻找危险因素。
主要发现
- 30天再入院率为2.9%。
- 计划外再入院最常见原因为手术部位感染。
- 不同神经外科疾病再入院原因差异显著(p < 0.001)。
- 多因素logistic回归显示脑积水(OR, 4)和初次住院时间较短(OR, 0.9)为再入院危险因素。
临床怎么用
- 可将30天再入院率作为质量追踪指标,但需结合再入院原因分析并考虑风险调整,不应单独用于质量评价。
局限性
- 单中心回顾性研究,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A shift in how we evaluate healthcare outcomes has driven the introduction of quality indicators as potential parameters to evaluate value-based healthcare delivery. So far, only few studies have been performed evaluating quality indicators in the context of neurosurgery, especially in the European region. The purpose of this study was to evaluate the 30-day readmission rate, identify reasons for readmission regarding the various neurosurgical diagnoses, and discuss the usefulness of this rate as a potential quality indicator. METHODS: During a 6-year period, a total of 8878 hospitalized patients in our neurosurgical department were retrospectively analyzed and included in this study. Reasons for readmission were identified. Patients' diagnoses and baseline characteristics were obtained in order to identify possible risk factors for readmission. RESULTS: The 30-day readmission rate was 2.9%. The most common reason for unplanned readmissions were surgical site infections. The reasons for readmissions varied significantly between the different underlying neurosurgical diseases (p < 0.001). Multivariate logistic regression revealed hydrocephalus (OR, 4) and shorter length of stay during index admission (OR, 0.9) as risk factors for readmission. CONCLUSIONS: We provided an analysis of reasons for readmission for various neurosurgical diseases in a large patient spectrum in Germany. Although readmission rates are easy to track and an attractive tool for quality assessment, the rate alone cannot be seen as an adequate measure for quality in neurosurgery as it lacks a homogenous definition and depends on the underlying health care system. In addition, strategies for risk adjustment are required.
引用
- Schipmann S, Suero Molina E, Windheuser J, et al. The 30-day readmission rate in neurosurgery-a useful indicator for quality assessment? Acta Neurochir (Wien). 2020. PMID: 32495079. doi:10.1007/s00701-020-04382-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。